SCOPUS 정보 검색 플랫폼

Journal of Biological Inorganic Chemistry

Volumn 19, Issue 6, 2014, Pages 1025-1035

Growth inhibitory effects of the Diruthenium-Ibuprofen compound, [Ru 2Cl(Ibp)4], in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo

(6) Benadiba, Marcel a De M Costa, Iguatinã a Santos, Rodrigo L S R a Serachi, Fernanda Oliveira a De Oliveira Silva, Denise a Colquhoun, Alison a

a UNIVERSITY OF SÃO PAULO (Brazil)

Author keywords

Cancer; Diruthenium; Glioma; Ibuprofen; Osmotic pump

Indexed keywords

ANTINEOPLASTIC AGENT; DIRUTHENIUM IBUPROFEN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; RUTHENIUM DERIVATIVE; UNCLASSIFIED DRUG; IBUPROFEN; ORGANOMETALLIC COMPOUND; RUTHENIUM;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CHRONIC TOXICITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG FECES LEVEL; DRUG STRUCTURE; DRUG TISSUE LEVEL; ENZYME INHIBITION; FEMALE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFUSION RATE; LEUKOCYTE COUNT; LOW DRUG DOSE; LYMPHOCYTE COUNT; MONOCYTE; NEUTROPHIL COUNT; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; SINGLE DRUG DOSE; STRUCTURE ANALYSIS; TUMOR XENOGRAFT; ANIMAL; APOPTOSIS; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOMA; HUMANS; IBUPROFEN; MOLECULAR STRUCTURE; NEOPLASMS, EXPERIMENTAL; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; RUTHENIUM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84905825421 PISSN: 09498257 EISSN: 14321327 Source Type: Journal
DOI: 10.1007/s00775-014-1143-4 Document Type: Article

Times cited : (29)

References (33)

1
- 77949332954
- Armstrong TS (2009) Oncol Nurs Forum 36:E 232-240.
- (2009) Oncol Nurs Forum , vol.36
- Armstrong, T.S.¹

2
- 70349385649
- 19628430 10.1016/S1470-2045(09)70192-5
- Bredel M (2009) Lancet Oncol 10:928-929
- (2009) Lancet Oncol , vol.10 , pp. 928-929
- Bredel, M.¹

3
- 70350461699
- 1:CAS:528:DC%2BD1MXhtlGgtbbM 19720927 10.1200/JCO.2008.19.8721
- Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T (2009) J Clin Oncol 27:4733-4740
- (2009) J Clin Oncol , vol.27 , pp. 4733-4740
- Friedman, H.S.¹ Prados, M.D.² Wen, P.Y.³ Mikkelsen, T.⁴ Schiff, D.⁵ Abrey, L.E.⁶ Yung, W.K.⁷ Paleologos, N.⁸ Nicholas, M.K.⁹ Jensen, R.¹⁰ Vredenburgh, J.¹¹ Huang, J.¹² Zheng, M.¹³ Cloughesy, T.¹⁴

4
- 65349121788
- 1:CAS:528:DC%2BD1MXlsVKhs74%3D 19269895 10.1016/S1470-2045(09)70025-7
- Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO (2009) Lancet Oncol 10:459-466
- (2009) Lancet Oncol , vol.10 , pp. 459-466
- Stupp, R.¹ Hegi, M.E.² Mason, W.P.³ Van Den Bent, M.J.⁴ Taphoorn, M.J.⁵ Janzer, R.C.⁶ Ludwin, S.K.⁷ Allgeier, A.⁸ Fisher, B.⁹ Belanger, K.¹⁰ Hau, P.¹¹ Brandes, A.A.¹² Gijtenbeek, J.¹³ Marosi, C.¹⁴ Vecht, C.J.¹⁵ Mokhtari, K.¹⁶ Wesseling, P.¹⁷ Villa, S.¹⁸ Eisenhauer, E.¹⁹ Gorlia, T.²⁰ more..

5
- 48649096955
- 1:CAS:528:DC%2BD1cXovVCntrg%3D 18632651 10.1158/0008-5472.CAN-07-5973
- Wheeler CJ, Black KL, Liu G, Mazer M, Zhang XX, Pepkowitz S, Goldfinger D, Ng H, Irvin D, Yu JS (2008) Cancer Res 68:5955-5964
- (2008) Cancer Res , vol.68 , pp. 5955-5964
- Wheeler, C.J.¹ Black, K.L.² Liu, G.³ Mazer, M.⁴ Zhang, X.X.⁵ Pepkowitz, S.⁶ Goldfinger, D.⁷ Ng, H.⁸ Irvin, D.⁹ Yu, J.S.¹⁰

6
- 16544389191
- Toward a glioblastoma vaccine: Promise and potential pitfalls
- DOI 10.1200/JCO.2004.06.927
- Fine HA (2004) J Clin Oncol 22:4240-4243 (Pubitemid 41185143)
- (2004) Journal of Clinical Oncology , vol.22 , Issue.21 , pp. 4240-4243
- Fine, H.A.¹

7
- 16544392098
- Antitumor vaccination of patients with glioblastoma multiforme: A pilot study to assess feasibility, safety, and clinical benefits
- DOI 10.1200/JCO.2004.09.038
- Steiner HH, Bonsanto MM, Beckhove P, Brysch M, Geletneky K, Ahmadi R, Schuele-Freyer R, Kremer P, Ranaie G, Matejic D, Bauer H, Kiessling M, Kunze S, Schirrmacher V, Herold-Mende C (2004) J Clin Oncol 22:4272-4281 (Pubitemid 41185148)
- (2004) Journal of Clinical Oncology , vol.22 , Issue.21 , pp. 4272-4281
- Steiner, H.H.¹ Bonsanto, M.M.² Beckhove, P.³ Brysch, M.⁴ Geletneky, K.⁵ Ahmadi, R.⁶ Schuele-Freyer, R.⁷ Kremer, P.⁸ Ranaie, G.⁹ Matejic, D.¹⁰ Bauer, H.¹¹ Kiessling, M.¹² Kunze, S.¹³ Schirrmacher, V.¹⁴ Herold-Mende, C.¹⁵

8
- 80054763805
- 1:CAS:528:DC%2BC3MXhsVCrsrzN 3213071 22017800 10.1186/1748-717X-6-141
- Niewald M, Berdel C, Fleckenstein J, Licht N, Ketter R, Rube C (2011) Radiat Oncol 6:141
- (2011) Radiat Oncol , vol.6 , pp. 141
- Niewald, M.¹ Berdel, C.² Fleckenstein, J.³ Licht, N.⁴ Ketter, R.⁵ Rube, C.⁶

9
- 0035301778
- 1:CAS:528:DC%2BD3MXltVOgsLs%3D
- Allardyce CS, Dyson PJ (2001) Platin Met Rev 45:62-69
- (2001) Platin Met Rev , vol.45 , pp. 62-69
- Allardyce, C.S.¹ Dyson, P.J.²

10
- 0042948708
- 1:CAS:528:DC%2BD3sXkvVyqtw%3D%3D 10.1016/S0010-8545(02)00312-0
- Clarke MJ (2003) Coord Chem Rev 236:209-233
- (2003) Coord Chem Rev , vol.236 , pp. 209-233
- Clarke, M.J.¹

11
- 33750295521
- 10.1002/ejic.200600723
- Ang WH, Dyson PJ (2006) Eur J Inorg Chem 20:4003-4018
- (2006) Eur J Inorg Chem , vol.20 , pp. 4003-4018
- Ang, W.H.¹ Dyson, P.J.²

12
- 34250614736
- 1:CAS:528:DC%2BD2sXmvVeltL0%3D 10.1016/j.ccr.2006.11.017
- Ronconi L, Sadler PJ (2007) Coord Chem Rev 251:1633-1648
- (2007) Coord Chem Rev , vol.251 , pp. 1633-1648
- Ronconi, L.¹ Sadler, P.J.²

13
- 37249031349
- Antitumour metal compounds: More than theme and variations
- DOI 10.1039/b712656p
- Jakupec MA, Galanski M, Arion VB, Hartinger CG, Keppler BK (2008) Dalton Trans 2:183-194 (Pubitemid 350278321)
- (2008) Dalton Transactions , Issue.2 , pp. 183-194
- Jakupec, M.A.¹ Galanski, M.² Arion, V.B.³ Hartinger, C.G.⁴ Keppler, B.K.⁵

14
- 75849158241
- 1:CAS:528:DC%2BC3cXlslWlurg%3D 21305154 10.1039/b904071d
- Levina A, Mitra A, Lay PA (2009) Metallomics 1:458-470
- (2009) Metallomics , vol.1 , pp. 458-470
- Levina, A.¹ Mitra, A.² Lay, P.A.³

15
- 75749151659
- 10.1039/b916860p
- Fink GS (2010) Dalton Trans 39:1673-1688
- (2010) Dalton Trans , vol.39 , pp. 1673-1688
- Fink, G.S.¹

16
- 78651068294
- 1:CAS:528:DC%2BC3cXhsVeksb3N 3018145 21077686 10.1021/jm100020w
- Gasser G, Ott I, Metzler-Nolte N (2011) J Med Chem 54:3-25
- (2011) J Med Chem , vol.54 , pp. 3-25
- Gasser, G.¹ Ott, I.² Metzler-Nolte, N.³

17
- 79952186235
- 1:CAS:528:DC%2BC3MXisFKnsbg%3D 10.1016/j.jorganchem.2010.11.009
- Ang WH, Casini A, Sava G, Dyson PJ (2011) Organomet Chem 696:989-998
- (2011) Organomet Chem , vol.696 , pp. 989-998
- Ang, W.H.¹ Casini, A.² Sava, G.³ Dyson, P.J.⁴

18
- 81355161135
- 1:CAS:528:DC%2BC3MXhsFOgtbfN 22112845 10.1016/j.jinorgbio.2011.09.030
- Bergamo A, Gaiddon C, Schellens JHM, Beijnen JH, Sava G (2012) J Inorg Biochem 106:90-99
- (2012) J Inorg Biochem , vol.106 , pp. 90-99
- Bergamo, A.¹ Gaiddon, C.² Schellens, J.H.M.³ Beijnen, J.H.⁴ Sava, G.⁵

19
- 84865464514
- 1:CAS:528:DC%2BC38XhtVejurzN 10.1021/om300373t
- Hartinger CG, Metzler-Nolte N, Dyson PJ (2012) Organometallics 31:5677-5685
- (2012) Organometallics , vol.31 , pp. 5677-5685
- Hartinger, C.G.¹ Metzler-Nolte, N.² Dyson, P.J.³

20
- 33745384809
- From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
- DOI 10.1016/j.jinorgbio.2006.02.013, PII S0162013406000754
- Hartinger CG, Z-Seifred S, Jakupec MA, Kynast B, Zorbas H, Keppler B (2006) J Inorg Biochem 100:891-904 (Pubitemid 44308176)
- (2006) Journal of Inorganic Biochemistry , vol.100 , Issue.5-6 , pp. 891-904
- Hartinger, C.G.¹ Zorbas-Seifried, S.² Jakupec, M.A.³ Kynast, B.⁴ Zorbas, H.⁵ Keppler, B.K.⁶

21
- 10844269461
- Ruthenium antimetastatic agents
- DOI 10.2174/1568026043387421
- Alessio E, Mestroni G, Bergamo A, Sava G (2004) Curr Top Med Chem 4:1525-1535 (Pubitemid 39662663)
- (2004) Current Topics in Medicinal Chemistry , vol.4 , Issue.15 , pp. 1525-1535
- Alessio, E.¹ Mestroni, G.² Bergamo, A.³ Sava, G.⁴

22
- 77951657184
- 10.2174/187152010791162333
- de Oliveira Silva D (2010) Anticancer Agents Med Chem 10:312-323
- (2010) Anticancer Agents Med Chem , vol.10 , pp. 312-323
- De Oliveira Silva, D.¹

23
- 38749118595
- 1:CAS:528:DC%2BD1cXhslarsLs%3D 10.1016/j.poly.2007.12.011
- Ribeiro G, Benadiba M, Colquhoun A (2008) de Oliveira Silva D. Polyhedron 27:1131-1137
- (2008) Polyhedron , vol.27 , pp. 1131-1137
- Ribeiro, G.¹ Benadiba, M.² Colquhoun, A.³ De Oliveira Silva, D.⁴

24
- 77955086102
- 1:CAS:528:DC%2BC3cXptlahu7k%3D 20605638 10.1016/j.jinorgbio.2010.04.011
- Benadiba M, Santos RR, de Oliveira Silva D, Colquhoun A (2010) J Inorg Biochem 104:928-935
- (2010) J Inorg Biochem , vol.104 , pp. 928-935
- Benadiba, M.¹ Santos, R.R.² De Oliveira Silva, D.³ Colquhoun, A.⁴

25
- 0032007885
- Effects of saturated and polyunsaturated fatty acids on human tumor-cell proliferation
- DOI 10.1016/S0306-3623(97)00110-9, PII S0306362397001109
- Colquhoun A, Curi R (1998) Gen Pharmacol 30:191-194 (Pubitemid 28026720)
- (1998) General Pharmacology , vol.30 , Issue.2 , pp. 191-194
- Colquhoun, A.¹ Curi, R.²

26
- 0031971967
- 1:CAS:528:DyaK1cXislWhtb4%3D 9570691 10.1002/(SICI)1099-1263(199803/04) 18:2<93: AID-JAT472>3.0.CO;2-W
- Kersten L, Bräunlich H, Keppler BK, Gliesing C, Wendelin M, Westphal J (1998) J Appl Toxicol 18:93-101
- (1998) J Appl Toxicol , vol.18 , pp. 93-101
- Kersten, L.¹ Bräunlich, H.² Keppler, B.K.³ Gliesing, C.⁴ Wendelin, M.⁵ Westphal, J.⁶

27
- 0041303668
- Protective role of glucose-6-phosphate dehydrogenase activity in the metabolic response of C6 rat glioma cells to polyunsaturated fatty acid exposure
- DOI 10.1002/glia.10246
- Ramos KL, Colquhoun A (2003) Glia 43:149-166 (Pubitemid 36897276)
- (2003) GLIA , vol.43 , Issue.2 , pp. 149-166
- Ramos, K.L.¹ Colquhoun, A.²

28
- 59449101302
- 1:CAS:528:DC%2BD1MXhvVSitLk%3D 19209025 10.1097/CAD.0b013e328322fbc5
- Lentz F, Drescher A, Lindauer A, Henke M, Hilger RA, Hartinger CG, Scheulen ME, Dittrich C, Keppler BK, Jaehde U (2009) Anticancer Drugs 20:97-103
- (2009) Anticancer Drugs , vol.20 , pp. 97-103
- Lentz, F.¹ Drescher, A.² Lindauer, A.³ Henke, M.⁴ Hilger, R.A.⁵ Hartinger, C.G.⁶ Scheulen, M.E.⁷ Dittrich, C.⁸ Keppler, B.K.⁹ Jaehde, U.¹⁰

29
- 63349083680
- 2661078 19292920 10.1186/1476-511X-8-8
- Miyake JA, Benadiba M, Colquhoun A (2009) Lipids Health Dis 8:8
- (2009) Lipids Health Dis , vol.8 , pp. 8
- Miyake, J.A.¹ Benadiba, M.² Colquhoun, A.³

30
- 61349089240
- 1:CAS:528:DC%2BD1MXitlWgtrg%3D 19208740 10.1158/1541-7786.MCR-08-0428
- Batista LF, Roos WP, Kaina B, Menck CF (2009) Mol Cancer Res 7:237-246
- (2009) Mol Cancer Res , vol.7 , pp. 237-246
- Batista, L.F.¹ Roos, W.P.² Kaina, B.³ Menck, C.F.⁴

31
- 0021352405
- 1:CAS:528:DyaL2cXitVartLY%3D 6363936 10.1056/NEJM198403013100905
- Clive DM, Stoff JS (1984) N Engl J Med 310:563-572
- (1984) N Engl J Med , vol.310 , pp. 563-572
- Clive, D.M.¹ Stoff, J.S.²

32
- 0019135753
- 1:CAS:528:DyaL3MXlslOkug%3D%3D 7007713 10.1038/ki.1980.179
- Dunn MJ, Zambraski EJ (1980) Kidney Int 18:609-622
- (1980) Kidney Int , vol.18 , pp. 609-622
- Dunn, M.J.¹ Zambraski, E.J.²

33
- 84902126606
- Miyake JA, Benadiba M, Ribeiro G, de Oliveira Silva D, Colquhoun A (2014) Anticancer Res 34(4):1901-1911 Nível Superior
- (2014) Anticancer Res , vol.34 , Issue.4 , pp. 1901-1911
- Miyake, J.A.¹ Benadiba, M.² Ribeiro, G.³ De Oliveira Silva, D.⁴ Colquhoun, A.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.